Healthcare Value Capital’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Healthcare Value Capital’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-50,000	Closed	-$269K	–	31
2016 Q1	$269K	Hold	50,000	–	–	0.4%	27
2015 Q4	$436K	Hold	50,000	–	–	0.72%	19
2015 Q3	$420K	Hold	50,000	–	–	0.6%	23
2015 Q2	$881K	Sell	50,000 -75,000	-60%	-$964K	0.93%	21
2015 Q1	$1.45M	Sell	125,000 -55,479	-31%	-$642K	1.57%	17
2014 Q4	$1.82M	Sell	180,479 -60,489	-25%	-$306K	3.32%	10
2014 Q3	$1.09M	Buy	240,968 +36,000	+18%	+$193K	1.05%	19
2014 Q2	$1.38M	Buy	204,968 +104,968	+105%	+$792K	1.16%	19
2014 Q1	$1.28M	Buy	+100,000	New	+$1.11M	0.84%	27

Other funds holding SRNE

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Healthcare Value Capital's SRNE Position: Q2 2016 in Review

Healthcare Value Capital sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2016, closing a stake of 50,000 shares — an estimated $269K sold.

Healthcare Value Capital first reported a position in SRNE in Q1 2014 and held it in 9 quarters. The position peaked at $1.82M in Q4 2014. 62 funds tracked by Wall St. Rank hold SRNE as of Q2 2016.

Healthcare Value Capital reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
Healthcare Value Capital sold 50,000 Sorrento Therapeutics, Inc. shares in Q2 2016, an estimated $269K.
Healthcare Value Capital first reported a position in Sorrento Therapeutics, Inc. in Q1 2014 and held it in 9 quarters.
Healthcare Value Capital's Sorrento Therapeutics, Inc. position peaked at $1.82M in Q4 2014.
62 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2016.

Based on Healthcare Value Capital's 13F filing for Q2 2016, filed 15 Aug 2016.